FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26 | -18.8% | 3,460 | -4.8% | 0.00% | – |
| Q2 2023 | $32 | -60.5% | 3,635 | -62.5% | 0.00% | – |
| Q1 2023 | $81 | -9.0% | 9,697 | +4.7% | 0.00% | – |
| Q4 2022 | $89 | -99.6% | 9,260 | +249.7% | 0.00% | – |
| Q3 2021 | $25,000 | +19.0% | 2,648 | -11.6% | 0.00% | – |
| Q2 2021 | $21,000 | -81.4% | 2,994 | -83.5% | 0.00% | – |
| Q1 2021 | $113,000 | +113.2% | 18,194 | +159.0% | 0.00% | – |
| Q4 2020 | $53,000 | -11.7% | 7,024 | -28.3% | 0.00% | – |
| Q3 2020 | $60,000 | -40.0% | 9,803 | -18.1% | 0.00% | – |
| Q2 2020 | $100,000 | +4900.0% | 11,965 | +2103.5% | 0.00% | – |
| Q2 2019 | $2,000 | -88.2% | 543 | -84.1% | 0.00% | – |
| Q1 2019 | $17,000 | -55.3% | 3,416 | -26.2% | 0.00% | – |
| Q3 2018 | $38,000 | +375.0% | 4,631 | +458.0% | 0.00% | – |
| Q2 2018 | $8,000 | – | 830 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Solas Capital Management, LLC | 849,979 | $3,400,000 | 3.47% |
| Southpoint Capital Advisors LP | 3,997,214 | $15,989,000 | 0.60% |
| Opaleye Management Inc. | 295,000 | $1,180,000 | 0.36% |
| 683 Capital Management, LLC | 971,351 | $3,885,000 | 0.35% |
| Avoro Capital Advisors LLC | 1,105,999 | $4,424,000 | 0.15% |
| Eventide Asset Management | 720,000 | $2,880,000 | 0.09% |
| Granahan Investment Management | 439,083 | $1,756,000 | 0.09% |
| Hartford Financial Management Inc. | 20,300 | $81,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 75,236 | $301,000 | 0.01% |
| Paloma Partners Management Co | 54,400 | $218,000 | 0.00% |